Navigation Links
Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline
Date:3/18/2008

REDWOOD CITY, Calif., March 18 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, has announced that they have extended and expanded their existing license agreement with GlaxoSmithKline for access to Ingenuity Pathways Analysis (IPA) software. The new agreement enables GSK to provide enterprise-wide IPA access to researchers for rapid assessment of the signaling and metabolic pathways, molecular networks, and biological processes that are most significant to disease targets. In addition, GSK will also use Ingenuity's content and proprietary algorithms.

"We are very pleased that GSK will now be able to leverage IPA and other Ingenuity information solutions at the enterprise level," stated Jake Leschly, CEO, Ingenuity Systems. "Many discovery programs at GSK have already successfully used IPA to understand the complex relationship between pathways and disease. Research teams across the organization will now be able to use these insights to make effective decisions as to which drug targets and compounds to pursue."

About Ingenuity Pathways Analysis

Ingenuity Pathways Analysis is an all-in-one software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA's search capabilities provide users with access to the highest quality detail-rich knowledge available on genes, drugs, chemicals, protein families, cellular and disease processes, and signaling and metabolic pathways. IPA supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and development process, including target identification and validation, biomarker discovery, molecular toxicology, metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in hundreds of peer-reviewed journals.

About Ingenuity Systems(R)

Ingenuity Systems is a leading provider of information solutions for the exploration, interpretation, and analysis of life science information. All of Ingenuity's products and services have one common goal -- to help life science researchers generate maximum value from all types of biological and chemical knowledge. Ingenuity offers a broad and flexible range of solutions that can be tailored to needs of various clients, including academic and therapeutic area researchers, computational biologists and informatics departments, and suppliers in the life sciences industry. All of the products leverage Ingenuity's knowledge base, the largest data base of its kind, which houses the biological and chemical relationships extracted from scientific literature. The information is uniquely structured so scientists can ask complex biological questions to gain rapid insight into their experimental data or create relevant biological models to move forward in their research. Today, Ingenuity's solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, and academic research institutions worldwide. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, Australia, and Japan. http://www.ingenuity.com.


'/>"/>
SOURCE Ingenuity Systems(R)
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ingenuity Systems Launches New Metabolomics Solution Within IPA
2. Ingenuity Systems Joins Biomarkers Consortium
3. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
4. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
5. DNA Testing Systems Inks Agreement with DNAPrint Genomics
6. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
7. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
8. Purdue leads center to simulate behavior of micro-electromechanical systems
9. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
10. IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology
11. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Franz Inc ., ... development tools, and market leader for Semantic Graph Database technology, today ... within the most effective system for developing and deploying applications to solve the ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... , Covalent’s Analytical Services unit provides high-quality data to clients, both ... 24 hours of receipt. There are no price premiums, and customers are welcome ...
(Date:4/24/2017)... ... April 24, 2017 , ... It is well ... milieu; however, the broad application of this cellular target engagement concept to drug ... readouts. Cell-based thermal stabilization assays are valuable methods for particular applications, but they ...
Breaking Biology Technology:
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
(Date:3/7/2017)... March 7, 2017 Brandwatch , the leading social ... The Prince,s Trust to uncover insights to support its reporting, ... The UK,s leading youth charity will be using Brandwatch ... and get a better understanding of the topics and issues that ... ...
Breaking Biology News(10 mins):